BIOCERES CROP SOLUTIONS CORP. Revenue
BIOCERES CROP SOLUTIONS CORP. (BIOX) reported Revenue of $73.81 million for the 3-month period ending 2025-12-31, per its 6-K filed 2026-03-13.
Financial Statements › Income Statement › Other Income
ifrs-full:Revenue · last filed 2026-03-13
- BIOCERES CROP SOLUTIONS CORP. revenue for the quarter ending 2025-12-31 was $73.81M, a 25.30% decline year-over-year.
- BIOCERES CROP SOLUTIONS CORP. revenue for the quarter ending 2025-09-30 was $77.60M, a 16.82% decline year-over-year.
- BIOCERES CROP SOLUTIONS CORP. revenue for the quarter ending 2025-06-30 was $74.55M, a 39.87% decline year-over-year.
- BIOCERES CROP SOLUTIONS CORP. revenue for the quarter ending 2025-03-31 was $60.59M, a 27.86% decline year-over-year.
| Period end | Revenue 3 month | Revenue 3 month as first filed | Revenue 6 month | Revenue 6 month as first filed | Revenue 9 month | Revenue 9 month as first filed | Revenue 12 month | Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $73.81M 6-K · filed 2026-03-13 | $142.93M 6-K · filed 2026-03-13 | $225.96M derived: sum of 3 quarters · filed 2026-03-13 | $286.54M derived: sum of 4 quarters · filed 2026-03-13 | ||||
| 2025-09-30 | $77.60M 6-K · filed 2025-11-26 | $152.15M derived: sum of 2 quarters · filed 2025-11-26 | $212.74M derived: sum of 3 quarters · filed 2025-11-26 | $311.54M derived: sum of 4 quarters · filed 2026-03-13 | ||||
| 2025-06-30 | $74.55M derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10 | $135.14M derived: sum of 2 quarters · filed 2025-11-10 | $233.94M derived: sum of 3 quarters · filed 2026-03-13 | $335.11M 20-F · filed 2025-11-10 | ||||
| 2025-03-31 | $60.59M 6-K · filed 2025-06-20 | $159.39M derived: sum of 2 quarters · filed 2026-03-13 | $260.56M 6-K · filed 2025-06-20 | $376.66M derived: sum of 4 quarters · filed 2026-03-13 | ||||
| 2024-12-31 | $98.80M 6-K · filed 2026-03-13 | $106.68M 6-K · filed 2025-02-28 | $182.90M 6-K · filed 2026-03-13 | $199.97M 6-K · filed 2025-02-28 | $316.08M derived: sum of 3 quarters · filed 2026-03-13 | $400.06M derived: sum of 4 quarters · filed 2026-03-13 | ||
| 2024-09-30 | $93.29M 6-K · filed 2025-11-26 | $217.27M derived: sum of 2 quarters · filed 2025-11-26 | $301.26M derived: sum of 3 quarters · filed 2025-11-26 | $441.48M derived: sum of 4 quarters · filed 2025-11-26 | ||||
| 2024-06-30 | $123.99M derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10 | $207.97M derived: sum of 2 quarters · filed 2025-11-10 | $348.19M derived: sum of 3 quarters · filed 2025-11-10 | $464.78M 20-F · filed 2025-11-10 | ||||
| 2024-03-31 | $83.98M 6-K · filed 2025-06-20 | $224.20M derived: sum of 2 quarters · filed 2025-06-20 | $340.80M 6-K · filed 2025-06-20 | $445.50M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2023-12-31 | $140.22M 6-K · filed 2025-02-28 | $256.81M 6-K · filed 2025-02-28 | $361.52M derived: sum of 3 quarters · filed 2025-11-10 | $454.02M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2023-09-30 | $116.59M 6-K · filed 2024-11-27 | $221.30M derived: sum of 2 quarters · filed 2025-11-10 | $313.80M derived: sum of 3 quarters · filed 2025-11-10 | $406.70M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2023-06-30 | $104.71M derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10 | $197.20M derived: sum of 2 quarters · filed 2025-11-10 | $290.10M derived: sum of 3 quarters · filed 2025-11-10 | $420.06M 20-F · filed 2025-11-10 | $415.71M 20-F · filed 2023-11-14 | |||
| 2023-03-31 | $92.49M 6-K · filed 2023-05-24 | $185.39M derived: sum of 2 quarters · filed 2023-05-24 | $315.35M 6-K · filed 2024-05-29 | $312.50M 6-K · filed 2023-05-24 | $418.52M derived: sum of 4 quarters · filed 2024-10-30 | |||
| 2022-12-31 | $92.90M 6-K · filed 2023-02-28 | $221.74M 6-K · filed 2024-02-28 | $220.01M 6-K · filed 2023-02-28 | $326.03M derived: sum of 3 quarters · filed 2024-10-30 | $395.51M derived: sum of 4 quarters · filed 2024-10-30 | |||
| 2022-09-30 | $127.33M 6-K · filed 2023-11-29 | $233.13M derived: sum of 2 quarters · filed 2024-10-30 | $302.61M derived: sum of 3 quarters · filed 2024-10-30 | $395.27M derived: sum of 4 quarters · filed 2024-10-30 | ||||
| 2022-06-30 | $105.79M derived: 20-F 12 month − 6-K 9 month · filed 2024-10-30 | $175.27M derived: sum of 2 quarters · filed 2024-10-30 | $267.94M derived: sum of 3 quarters · filed 2024-10-30 | $334.84M 20-F · filed 2024-10-30 | $334.80M 20-F · filed 2022-10-28 | |||
| 2022-03-31 | $69.48M 6-K · filed 2023-05-24 | $162.15M derived: sum of 2 quarters · filed 2023-05-24 | $229.05M 6-K · filed 2023-05-24 | |||||
| 2021-12-31 | $92.66M 6-K · filed 2023-02-28 | $159.57M 6-K · filed 2023-02-28 | ||||||
| 2021-06-30 | $209.53M 20-F · filed 2023-11-14 | |||||||
| 2020-12-31 | $48.74M 6-K · filed 2022-02-25 | $91.09M 6-K · filed 2022-02-25 | ||||||
| 2020-06-30 | $173.09M 20-F · filed 2022-10-28 | |||||||
| 2019-12-31 | $62.99M 6-K · filed 2021-02-26 | $99.25M 6-K · filed 2021-02-26 | ||||||
| 2019-06-30 | $160.61M 20-F · filed 2021-10-29 | |||||||
| 2018-12-31 | $92.07M 6-K/A · filed 2020-03-17 | |||||||
| 2018-06-30 | $133.54M 20-F · filed 2020-10-21 | |||||||
| 2016-12-31 | $41.17M 20-F · filed 2019-10-24 |